Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 137
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | ||
| NCT01540110 | Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses | ||
| NCT06093061 | Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma | ||
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | ||
| NCT06766058 | Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. | ||
| NCT05957068 | Breast Cancer Exercise Intervention Study | ||
| NCT05724264 | SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE) | ||
| NCT06194084 | Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers | ||
| NCT01029418 | AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma | ||
| NCT03100006 | Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | ||
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | ||
| NCT04242251 | Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study | ||
| NCT06172595 | FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma | ||
| NCT04961489 | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes | ||
| NCT03325218 | Survival Expectations and Hope Among Cancer Patients at End-of-Life | ||
| NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | ||
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | ||
| NCT07521670 | Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) | ||
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer | ||
| NCT05286437 | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | ||
| NCT05516628 | Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma | ||
| NCT04087473 | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC | ||
| NCT01570296 | A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR | ||
| NCT02368860 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | ||
| NCT06160843 | Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma | ||
| NCT01341834 | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors | ||
| NCT02931864 | Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors | ||
| NCT01022723 | Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells | ||
| NCT04224480 | Longitudinal Immune-phenotyping of HCC Following MK-3475 | ||
| NCT02408497 | Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy | ||
| NCT04027647 | Phase 2 Study of Dacomitinib in NSCLC | ||
| NCT04230330 | Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma | ||
| NCT00467194 | Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | ||
| NCT02736305 | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer | ||
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT05148572 | Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma | ||
| NCT04104113 | Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial | ||
| NCT02850640 | Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study | ||
| NCT04632173 | Head and Neck cancERs International cOviD-19 collabOraTion | ||
| NCT04738708 | Telegenetics or In-Person Genetic Counselling | ||
| NCT01765686 | Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery | ||
| NCT02806388 | Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project | ||
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | ||
| NCT03188159 | Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | ||
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | ||
| NCT04956068 | PIPAC for Peritoneal Metastases | ||
| NCT00263484 | Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | ||
| NCT06956248 | Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) | ||
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | ||
| NCT01100801 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients |
